AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.

  1. October 15, 2021

    Zydus Infringed AstraZeneca's Diabetes Drug IP, Judge Rules

    A Delaware federal judge held Friday that Zydus Pharmaceuticals infringed an AstraZeneca patent for a diabetes drug, saying Zydus failed during a four-day bench trial to prove that any of the asserted claims were obvious.

  2. May 13, 2021

    IP Forecast: Cox Case To Restart Patent Jury Trials In Del.

    Cox Communications is getting ready to defend its high-speed networking technology from a patent-holding company's infringement claims in the first patent trial in Delaware federal court to go before a jury since the pandemic began — plus all the other major intellectual property matters that are on deck for the coming week.